PubMed · 14168830
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M MILNE. 1964. PYELONEPHRITIS.. https://pubmed.ncbi.nlm.nih.gov/14168830/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A microbial culture derived from a landfill site in Dover, DE consistently reduced trichloroethene (TCE) to ethene through 1,1-dichloroethene (DCE) as a dominant intermediate in the presence of ampicillin. A constant 1,1-DCE-to-cis-DCE ratio of 2.4 +/- 0.3 was observed for more than two years, while trans-DCE was never detected. Without ampicillin, however, TCE was reduced to ethene almost exclusively through cis-DCE, suggesting that the culture contained at leasttwo TCE-dechlorinating populations. Two subcultures, which were established using 1,1-DCE or vinyl chloride as an electron acceptor, exhibited the same 1,1-DCE-to-cis-DCE ratio when TCE was introduced. PCR amplification of 16S rRNA gene followed by sequencing and DGGE analysis indicate that these (sub)cultures contained a Dehalococcoides population(s). TCE dechlorination assays with crude cell extract showed a DCE distribution pattern similar to that with whole cells. The enzyme involved in 1,1-DCE formation was likely a cobalt corrinoid enzyme, as suggested by the inhibitory effect of CH3I and photoreversibility of the inhibition. This study provides a possible biological mechanism forthe occurrence of 1,1-DCE in TCE-contaminated sites.
The solubility of non cross-linked chitosan in weak acid solutions restricts its utility in microspheres for drug delivery. The primary aim of this study was to produce pentasodium tripolyphosphate cross-linked chitosan microspheres with higher acid resistance for controlled release of ampicillin. The microspheres were prepared by two different microencapsulation procedures (by emulsification and by spray-drying) and characterized by their particle size, surface morphology, stability, drug entrapment efficiency and drug release. The size of the microspheres was <10 microm with a narrow size distribution. The entrapment of ampicillin in the microspheres was more than 80%. Stability of uncross-linked and cross-linked microspheres was affected by the pH of simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 7.5). The inclusion of the enzymes pepsin and pancreatin did not affect the stability of the microspheres. The inclusion of lysozyme in phosphate buffer saline resulted in increased solubilization. The release of the drug was affected by cross-linking of microspheres with tripolyphosphate (TPP). The cross-linked microspheres were more stable in simulated gastric fluid and showed slower but sustained release of ampicillin. The antimicrobial activity of the released ampicillin was confirmed by Staphylococcus aureus bioassay.
OBJECTIVE: To report a case in which ampicillin was used successfully as lock therapy for a central venous intravascular catheter and to discuss the implications of ampicillin used in this modality. CASE SUMMARY: A 14-month-old girl with a long-term central venous catheter acquired a polymicrobial (Escherichia coli and Enterococcus durans) bloodstream infection. The central venous catheter was suspected as the source for the bacteremia based on the timing and number of positive blood cultures in relation to therapy with antibiotics. Antibiotic sensitivity testing revealed ampicillin monotherapy to be an ideal choice to treat both organisms. A combination of systemic therapy via a temporary catheter and antibiotic lock therapy of the central venous catheter was then instituted using ampicillin without anticoagulants. The patient tolerated this therapy without complications, and follow-up cultures demonstrated effective clearance of the bacteria. DISCUSSION: Antibiotic lock therapy has been shown to be useful in the treatment of catheter-related bloodstream infections. However, many antibiotics have yet to be tested with this modality. Ampicillin, which is frequently used in the treatment of Enterococcus and E. coli infections, has not previously been reported as a single agent for lock therapy. CONCLUSIONS: Ampicillin may be a useful agent with the relatively new modality of lock therapy for central venous catheters. Further studies are needed to demonstrate possible compatibility of this agent with anticoagulants, such as heparin, as well as its efficacy in treating catheter-related bloodstream infections.